BRAF and central nervous system cancer: The IDH-wildtype astrocytic glioma classified as low-grade glioma MYB/MYBL1 by methylation profiling, was negative for IDH1/IDH2 and BRAF mutations by sequencing analysis and was 1p/19q non-codeleted.